- Covariates: c(Intercept, "age_at_diag", "disease_duration", "gender","white", "black")
- Treatments (in 'MS treatment sequences.csv'): 
# 1 = 121191 = B-cell depletion (rituximab + ocrelizumab)
# 2 = 214582 = glatiramer acetate
# 3 = NA = Interferon-beta
# 4 = 1373478 = dimethyl fumarate
# 5 = 354770 = natalizumab
# 6 = 1012892 = fingolimod
# 7 = 1310520 = teriflunomide
# 8 = 92299 = cyclophosphamide
# 9 = 7005 = mitoxantrone
# 10 = 117055 = alemtuzumab


B-cell depletion (rituximab + ocrelizumab), 
glatiramer acetate
Interferon-beta
dimethyl fumarate
natalizumab
fingolimod
teriflunomide
cyclophosphamide
mitoxantrone
alemtuzumab

- Treatments (in 'MS treatment sequences collapsed.csv'): 

1 = B-cell depletion (rituximab + ocrelizumab)  (original code = 1)
2 = glatiramer acetate                          (original code = 2)
3 = Interferon-beta                             (original code = 3)
4 = dimethyl fumarate                           (original code = 4)
5 = natalizumab                                 (original code = 5)
6 = S1P modulators (fingolimod + teriflunomide) (original code = 6,7)
7 = Aggressive / Legacy therapies (cyclophosphamide, mitoxantrone, alemtuzumab) (original code = 8, 9, 10)

